LongueVue Capital Expands Pinnacle Clinical Research Platform with Acquisition of Jubilee Clinical Research

LongueVue Capital (“LVC”) is pleased to announce that its portfolio company, Pinnacle Clinical Research (“Pinnacle” or the “Company”), a leading clinical trial site organization specializing in complex therapeutic areas, has acquired Jubilee Clinical Research, Inc. (“Jubilee”), a multi-therapeutic site based in Las Vegas, NV. This strategic acquisition strengthens Pinnacle’s expertise in metabolic and cardiovascular diseases and expands the Company’s footprint to the West Coast. Founded in 2017 by Dr. Elliot Shin, Jubilee specializes in executing complex metabolic and cardiovascular clinical trials. Jubilee’s indication focus not only complements that of Pinnacle, but also expands the Company into additional therapeutic areas with new pharmaceutical relationships.

Read the full article: LongueVue Capital Expands Pinnacle Clinical Research Platform with Acquisition of Jubilee Clinical Research //

Source: https://www.prnewswire.com/news-releases/longuevue-capital-expands-pinnacle-clinical-research-platform-with-acquisition-of-jubilee-clinical-research-302260580.html

Scroll to Top